+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Musculoskeletal Pain Drug"

Musculoskeletal Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Musculoskeletal Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Musculoskeletal Pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Musculoskeletal Pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Musculoskeletal Pain Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. It focuses on drugs used to treat pain associated with musculoskeletal disorders, such as arthritis, fibromyalgia, and osteoporosis. These drugs are typically used to reduce inflammation, improve mobility, and reduce pain. Commonly prescribed drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and opioids. Other treatments, such as physical therapy, exercise, and lifestyle modifications, may also be recommended. Some companies in the Musculoskeletal Pain Drug market include Pfizer, Merck, Novartis, and Johnson & Johnson. These companies produce a variety of drugs used to treat musculoskeletal pain, including NSAIDs, corticosteroids, and opioids. Other companies, such as AbbVie, Amgen, and Eli Lilly, also produce drugs used to treat musculoskeletal pain. Show Less Read more